StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

SNY — Sanofi

UNDERVALUED (MOS +47.8%) · Quality 66/100

Price
48.32
Intrinsic value
92.6
Margin of safety
+47.8%
Implied growth (reverse DCF)
-2.2%
model assumes +7.3%
Value Score
36.6
Quality
66
Psychology
-29.1
Discovery
7.4
price/volume attention only
Moat score
35
erosion: none

Value Score: top 44% of Foreign US-listed · Quality: top 38%

Dividend: 2.422/share (TTM) · yield 5.0% · payout 123%

Open the interactive Deep Dive for SNY →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/SNY - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is SNY undervalued?

As of 2026-11-11, SNY trades at 48.32 against a computed intrinsic value of 92.6 (+47.8% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Sanofi's Value Score?

Sanofi's Value Score is 36.6 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does SNY pay a dividend?

Yes - SNY's trailing twelve-month dividend is 2.422/share, a yield of 5.0% at the current price (as of 2026-11-11).